Author: OurCrowd

[Freightos in PR Newswire] Air Europa joins WebCargo by Freightos’ platform, expanding digital air cargo access in European and Latin American markets

Apr 2, 2025 |

BARCELONA, Spain, April 2, 2025 /PRNewswire/ — Freightos (NASDAQ: CRGO), the world’s leading vendor-neutral digital freight booking and payment platform, today announced that Air Europa, a leading Spanish airline, has joined WebCargo by Freightos’ cargo booking platform. With the addition of Air Europa, WebCargo strengthens its offering across key Spain-Latin America trade lanes, providing freight forwarders instant access to Air Europa’s extensive network of 15 domestic destinations within Spain and 40 international routes across Europe, North America, and Latin America. Read...

Read More

[Stoke Space in PR Newswire] QuesTek Innovations delivers breakthrough burn-resistant alloy for Stoke Space’s reusable rocket engines

Apr 2, 2025 |

EVANSTON, Ill., April 2, 2025 /PRNewswire/ —  QuesTek Innovations has successfully developed a novel nickel-based superalloy designed for additive manufacturing and extreme aerospace environments, marking a critical milestone in its collaboration with Stoke Space, a pioneering OEM developing reusable rockets designed to fly daily. The mission: enable high-performance, fully reusable launch systems with dramatically lower cost and higher launch frequency. Read More...

Read More

[Dandelion Energy in PR Newswire] Dandelion Energy and Lennar announce one of the largest residential geothermal deployments in US history

Apr 2, 2025 |

ARLINGTON, Va., April 2, 2025 /PRNewswire/ — Dandelion Energy, the nation’s leading home geothermal heating and cooling company, today announced they are partnering with Lennar Corporation (NYSE: LEN and LEN. B), one of the nation’s leading homebuilders, on one of the most significant residential geothermal heat pump deployments in US history. Read...

Read More

[Alpha Tau in Globe Newswire] Alpha Tau receives FDA approval to initiate a trial for patients with recurrent glioblastoma

Apr 2, 2025 |

JERUSALEM, April 02, 2025 (GLOBE NEWSWIRE) — Alpha Tau Medical Ltd. (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT®, announced today that the FDA has approved an Investigational Device Exemption (IDE) application to initiate a pilot study for the treatment of patients with recurrent glioblastoma (GBM) using the Alpha DaRT technology. Read...

Read More